Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)
Muller, William J
(PD/PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
10/25/19
→
8/31/50
Funding
MedImmune, Inc.
View all
View less